Ardelyx Inc (ARDX)
6.565
-0.14
(-2.16%)
USD |
NASDAQ |
Apr 17, 16:00
6.565
0.00 (0.00%)
After-Hours: 16:06
Ardelyx Shareholders Equity (Quarterly): 166.82M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 166.82M |
September 30, 2023 | 191.16M |
June 30, 2023 | 123.16M |
March 31, 2023 | 125.42M |
December 31, 2022 | 98.33M |
September 30, 2022 | 66.86M |
June 30, 2022 | 53.04M |
March 31, 2022 | 64.19M |
December 31, 2021 | 82.62M |
September 30, 2021 | 81.43M |
June 30, 2021 | 117.57M |
March 31, 2021 | 130.81M |
December 31, 2020 | 126.11M |
September 30, 2020 | 131.34M |
June 30, 2020 | 146.35M |
March 31, 2020 | 167.76M |
December 31, 2019 | 186.66M |
September 30, 2019 | 49.16M |
June 30, 2019 | 68.62M |
March 31, 2019 | 91.84M |
December 31, 2018 | 115.81M |
Date | Value |
---|---|
September 30, 2018 | 141.45M |
June 30, 2018 | 163.41M |
March 31, 2018 | 128.98M |
December 31, 2017 | 139.31M |
September 30, 2017 | 126.64M |
June 30, 2017 | 144.98M |
March 31, 2017 | 167.68M |
December 31, 2016 | 193.15M |
September 30, 2016 | 222.89M |
June 30, 2016 | 140.60M |
March 31, 2016 | 167.75M |
December 31, 2015 | 108.90M |
September 30, 2015 | 125.13M |
June 30, 2015 | 142.26M |
March 31, 2015 | 58.00M |
December 31, 2014 | 60.68M |
September 30, 2014 | 63.30M |
June 30, 2014 | 62.87M |
March 31, 2014 | -1.244M |
December 31, 2013 | -7.324M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
49.16M
Minimum
Sep 2019
191.16M
Maximum
Sep 2023
114.60M
Average
123.16M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
Nektar Therapeutics | 130.99M |
Omeros Corp | -24.98M |
Vistagen Therapeutics Inc | 123.28M |
Karyopharm Therapeutics Inc | -136.21M |
Adverum Biotechnologies Inc | 83.47M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 297.58M |
Total Liabilities (Quarterly) | 130.76M |
Debt to Equity Ratio | 0.2987 |
Current Ratio | 4.884 |
Net Debt Paydown Yield | -0.32% |